Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuelle Viguier

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Clinical and Experimental Dermatology|January 26, 2023
Treatment of dissecting cellulitis of the scalp with tumour necrosis factor inhibitors: a retrospective multicentre studyMuslih Alzahrani, Victor Coste, Maria Polina Konstantinou, et al.
Molecular Cancer|August 31, 2013
Cancer risk in immune-mediated inflammatory diseases (IMID)Rudi Beyaert, Laurent Beaugerie, Gert Van Assche, et al.
Acta Dermato-Venereologica|May 4, 2022
Impact of Childhood Onset Psoriasis on Addictive Behaviours, Socioeconomic and Educational Data in AdulthoodEmmanuel Mahé, Florence Tubach, Denis Jullien, et al.
The Journal of Investigative Dermatology|March 26, 2021
Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in PemphigusMaud Maho-Vaillant, Corine Perals, Marie-Laure Golinski, et al.
Acta Dermato-Venereologica|November 22, 2021
Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq CohortThomas Bettuzzi, Hervé Bachelez, Marie Beylot-Barry, et al.
American Journal of Clinical Dermatology|May 22, 2023
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE TrialEric L Simpson, Jonathan I Silverberg, Jacob P Thyssen, et al.
Dermatology (Basel, Switzerland)|February 3, 2021
First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort PsobioteqFlorence Assan, Florence Tubach, Hugo Arlegui, et al.
The British Journal of Dermatology|September 23, 2025
Ustekinumab as a potential therapeutic agent in bullous pemphigoid: a biologic and clinical proof-of-concept studyVlada Koliadenko, Pascal Joly, Flora Lemaire, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 3, 2017
Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority TrialCatherine Goujon, Manuelle Viguier, Delphine Staumont-Sallé, et al.
The British Journal of Dermatology|January 23, 2023
Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq RegistryHelene Aubert, Hugo Arlegui, Yann De Rycke, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Dermatology|January 26, 2023
Treatment of dissecting cellulitis of the scalp with tumour necrosis factor inhibitors: a retrospective multicentre studyMuslih Alzahrani, Victor Coste, Maria Polina Konstantinou, et al.
Molecular Cancer|August 31, 2013
Cancer risk in immune-mediated inflammatory diseases (IMID)Rudi Beyaert, Laurent Beaugerie, Gert Van Assche, et al.
Acta Dermato-Venereologica|May 4, 2022
Impact of Childhood Onset Psoriasis on Addictive Behaviours, Socioeconomic and Educational Data in AdulthoodEmmanuel Mahé, Florence Tubach, Denis Jullien, et al.
The Journal of Investigative Dermatology|March 26, 2021
Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in PemphigusMaud Maho-Vaillant, Corine Perals, Marie-Laure Golinski, et al.
Acta Dermato-Venereologica|November 22, 2021
Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq CohortThomas Bettuzzi, Hervé Bachelez, Marie Beylot-Barry, et al.
American Journal of Clinical Dermatology|May 22, 2023
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE TrialEric L Simpson, Jonathan I Silverberg, Jacob P Thyssen, et al.
Dermatology (Basel, Switzerland)|February 3, 2021
First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort PsobioteqFlorence Assan, Florence Tubach, Hugo Arlegui, et al.
The British Journal of Dermatology|September 23, 2025
Ustekinumab as a potential therapeutic agent in bullous pemphigoid: a biologic and clinical proof-of-concept studyVlada Koliadenko, Pascal Joly, Flora Lemaire, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 3, 2017
Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority TrialCatherine Goujon, Manuelle Viguier, Delphine Staumont-Sallé, et al.
The British Journal of Dermatology|January 23, 2023
Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq RegistryHelene Aubert, Hugo Arlegui, Yann De Rycke, et al.
Pageof 12